Data suggest that PBA is under recognised by neurologists and psychiatrists and many cases go unrecognised or misdiagnosed. P
(PRWEB UK) 29 May 2014
In the peer-reviewed journal European Neurological Review, Jeffrey Cummings discusses the Pseudobulbar Affect – A Disabling but Under-recognised Consequence of Neurological Disease and Brain Injury.
Pseudobulbar affect (PBA) is a condition associated with common neurological diseases or brain injury that manifests as uncontrollable and inappropriate outbursts of laughter or crying. PBA exacts a severe burden on the patient and care-givers in terms of reduced social functioning and often results in the patient’s isolation. The pathophysiology of PBA is incompletely understood, but symptoms are thought to result from damage to neural pathways associated with motor functioning and emotional processing. Data suggest that PBA is under recognised by neurologists and psychiatrists and many cases go unrecognised or misdiagnosed. PBA has been successfully treated with psychoactive drugs, including antidepressants, but these do not have regulatory approval for use in this indication. A combination of dextromethorphan hydrobromide and quinidine sulphate (DM/Q) has demonstrated significant efficacy in reducing PBA symptoms and a favourable safety profile in a series of clinical trials and in regular clinical use. With the availability of an effective treatment for PBA symptoms, it becomes even more pressing to detect the condition so that patients can receive appropriate treatment.
To continue reading this peer-reviewed article in full for free please visit: http://www.touchneurology.com/articles/pseudobulbar-affect-disabling-under-recognised-consequence-neurological-disease-and-brain-i.
NOTE TO EDITORS:
touchNEUROLOGY (a division of Touch Medical Media) provides independent, cutting-edge, peer-reviewed content from world renowned physicians, designed to lead the debate on health and to engage, inform, and support physicians in improving patient outcomes globally.
touchNEUROLOGY.com provides an international platform for peer-reviewed content from industry-leading journals alongside other carefully selected sources and aims to support physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity within the field of neurology.
Our portfolio of peer-reviewed journals, European Neurological Review and US Neurology comprise of concise review articles which are designed to keep busy physicians up-to-date with the latest developments in their field and serve as a key reference resource for the international neurology community.